We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

250 hedge funds and large institutions have $465M invested in Editas Medicine in 2022 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 64 increasing their positions, 68 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more call options, than puts

Call options by funds: $15.7M | Put options by funds: $10.8M

8.38% more ownership

Funds ownership: 70.22% → 78.6% (+8.4%)

6% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 68

5% less funds holding

Funds holding: 264 → 250 (-14)

21% less first-time investments, than exits

New positions opened: 42 | Existing positions closed: 53

21% less capital invested

Capital invested by funds: $591M → $465M (-$126M)

Holders
250
Holders Change
-14
Holders Change %
-5.3%
% of All Funds
4.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
42
Increased
64
Reduced
68
Closed
53
Calls
$15.7M
Puts
$10.8M
Net Calls
+$4.89M
Net Calls Change
-$232K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$31.5M
2
WP
Woodline Partners
California
+$22.8M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$10.9M
4
Bank of America
Bank of America
North Carolina
+$4.42M
5
BlackRock
BlackRock
New York
+$3.91M

Top Sellers

Rank Fund Capital Flow
1
CSS
Cubist Systematic Strategies
Connecticut
-$4.61M
2
NAMA
Nikko Asset Management Americas
New York
-$4.36M
3
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
-$4.36M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3.06M
5
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$2.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
TWA
201
TCI Wealth Advisors
Arizona
$2.93K – – –
FA
202
Financial Avengers
California
$2.82K +$3.49K +318 New
ICM
203
Islay Capital Management
Texas
$2.66K – – –
SN
204
Sittner & Nelson
Oregon
$2.66K – – –
AF
205
Allworth Financial
California
$2.66K +$1.8K +164 +121%
WT
206
Whittier Trust
California
$2.64K – – –
MCC
207
Money Concepts Capital
Florida
$2.23K +$2.77K +252 New
LC
208
Lindbrook Capital
California
$2.18K +$2.7K +246 New
LFG
209
Larson Financial Group
Missouri
$2.16K – – –
FHA
210
First Horizon Advisors
Tennessee
$2.04K -$2.67K -243 -51%
BTI
211
Blue Trust Inc
Georgia
$2K – – –
CWM
212
CarsonAllaria Wealth Management
Illinois
$2K – – –
Daiwa Securities Group
213
Daiwa Securities Group
Japan
$2K +$845 +77 +39%
HPC
214
HM Payson & Co
Maine
$1.86K – – –
GIA
215
GHP Investment Advisors
Colorado
$1.77K – – –
WIM
216
Westside Investment Management
California
$1.7K – – –
QCG
217
Quadrant Capital Group
Ohio
$1.64K +$2.03K +185 New
BBPWM
218
Blue Bell Private Wealth Management
Pennsylvania
$1.59K – – –
SIS
219
Sound Income Strategies
Florida
$1.38K – – –
NC
220
NewSquare Capital
Pennsylvania
$1.33K +$1.65K +150 New
IRC
221
Investors Research Corp
Georgia
$1.11K – – –
KFI
222
Key Financial Inc
Pennsylvania
$1.05K – – –
TFGT
223
TS Financial Group (TSFG)
Illinois
$1K – – –
SBL
224
Sargent Bickham Lagudis
Colorado
$887 +$1.1K +100 New
TC
225
Truvestments Capital
Florida
$869 – – –
7 8
9
10 11

EDIT Hedge Fund Activity: Q4 2022 in Review

250 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q4 2022, worth a combined $465M — down 21% from $591M a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of EDIT and 42 opened new positions — a net loss of 11 holders — while 68 trimmed existing stakes and 64 added.

The largest buyer was State Street, adding an estimated $31.5M. The largest seller was Cubist Systematic Strategies, exiting entirely with an estimated $4.61M sold.

  • 250 institutional investors held Editas Medicine (EDIT) as of Q4 2022, down from 264 in Q3 2022.
  • Funds reported $465M of Editas Medicine stock for Q4 2022, down 21% quarter-over-quarter.
  • 42 funds opened new Editas Medicine positions in Q4 2022 and 53 closed out, a net change of -11 holders.
  • The largest Editas Medicine buyer in Q4 2022 was State Street, an estimated $31.5M added.
  • The largest Editas Medicine seller in Q4 2022 was Cubist Systematic Strategies, an estimated $4.61M sold.

Based on aggregated 13F filings for Q4 2022.